The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Alternating gemcitabine/nab-paclitaxel (GA) and 5-FU/leucovorin/irinotecan (FOLFIRI) as first-line treatment for de novo metastatic pancreatic cancer (MPC): Safety and effect.

Brett A.  Schroeder

No Relationships to Disclose

Margaret T.  Mandelson

No Relationships to Disclose

Vincent J.  Picozzi

Stock and Other Ownership Interests  - Amgen; Cigna; Johnson & Johnson; McKesson; Thermo Fisher Scientific

Consulting or Advisory Role - TriSalus Life Sciences

Research Funding - Abbvie; Celgene; FibroGen; Ipsen; Merck; NGM Biopharmaceuticals; NovoCure; Tyme